SYMDEKO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Nov 2023)
What this means for you
Registered since 01 May 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 May 2028: the §8 & §9 renewal).
Record
- Serial number
- 87504249
- Registration number
- 5460641
- Mark type
- Design + words
- Filed
- 25 Jun 2017
- Published for opposition
- 31 Oct 2017
- Registered
- 01 May 2018
- Next maintenance filing
- §8 & §9 renewal, due by 01 May 2028 (grace period to 01 Nov 2028)
- Attorney of record
- Kelli A. Ovies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 01 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 01 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2018 — USE AMENDMENT FILED
- 06 Mar 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 26 Dec 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Nov 2017 — POST PUBLICATION AMENDMENT - ENTERED
- 31 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED